Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.

The American journal of psychiatry - 1 Dec 2014

Wong Ma-Li, Dong Chuanhui, Flores Deborah L, Ehrhart-Bornstein Monika, Bornstein Stefan, Arcos-Burgos Mauricio, Licinio Julio

Abstract excerpt

OBJECTIVE: The authors compared the effectiveness of fluoxetine and desipramine treatment in a prospective double-blind pharmacogenetics study in first-generation Mexican Americans and examined the role of whole-exome functional gene variations in the patients' antidepressant response. METHOD: A total of 232 Mexican Americans who met DSM-IV criteria for major depressive disorder were randomly assigned to receive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Antidepressive Agents, Second-Generation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antidepressive Agents, Tricyclic

Share to Double-Blind Method

Share to Drug Administration Schedule

Share to Fluoxetine

Share to Mexican Americans

Share to Selective Serotonin Reuptake Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 25220861
DOI: 10.1176/appi.ajp.2014.12091165
PMCID: PMC5746054

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.PMID 25220861Read ↗

Leveraging DNA Methylation to Predict Treatment Response in Major Depressive Disorder: A Critical ReviewSemantic proximity Read ↗

Epigenome-Wide DNA Methylation in Unipolar Depression: Predictive Biomarker of Antidepressant Treatment Response?Semantic proximity Read ↗

Dynamic Epigenetic Changes During Antidepressant Pharmacotherapy in Major Depressive DisorderSemantic proximity Read ↗

Antidepressant pharmacogeneticsSemantic proximity Read ↗

Pharmacogenomics of antidepressant drugs.Semantic proximity Read ↗

Epigenetic Signatures in Antidepressant Treatment Response: a Methylome-wide Association Study in the EMC TrialSemantic proximity Read ↗

Genomic predictors of remission to antidepressant treatment in geriatric depression using genome-wide expression analyses: a pilot study.Semantic proximity Read ↗

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.Semantic proximity Read ↗

Methylome-wide association study of antidepressant use in Generation Scotland and the Netherlands Twin Register implicates the innate immune systemSemantic proximity Read ↗

From Pharmacogenetics to Pharmacogenomics: The Way toward the Personalization of Antidepressant TreatmentSemantic proximity Read ↗

Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication.Semantic proximity Read ↗

Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.